Clinical Trial Update: Endovenous Versus Liposomal Iron in CKD [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing endovenous iron to liposomal iron in patients with iron deficiency anemia due to chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• Endovenous iron (intravenous iron formulation)
• Liposomal Iron (liposomal iron)

Snippet

Sponsor: Federico II University | Conditions: Iron Deficiency Anemia, Chronic Kidney Disease | Phase 4 | Status: COMPLETED